AAAAAA
Results: 1-25/31
Authors:
SIMOVA J
BUBENIK J
JANDLOVA T
INDROVA M
Citation: J. Simova et al., IRRADIATED IL-2 GENE-MODIFIED PLASMACYTOMA VACCINES ARE MORE EFFICIENT THAN LIVE VACCINES, International journal of oncology, 12(5), 1998, pp. 1195-1198
Authors:
INDROVA M
BUBENIK J
ROSSNER P
ZEUTHEN J
JANDLOVA T
SOBOTA V
Citation: M. Indrova et al., IMMUNOGENICITY, IMMUNOSENSITIVITY AND CELL-SURFACE ADHESIVENESS OF TUMOR VACCINES CARRYING AN INSERTED CD80 GENE, International journal of oncology, 12(2), 1998, pp. 387-390
Authors:
VLK V
ROSSNER P
INDROVA M
BUBENIK J
SOBOTA V
Citation: V. Vlk et al., INTERLEUKIN-2 GENE-THERAPY OF SURGICAL MINIMAL RESIDUAL TUMOR DISEASE, International journal of cancer, 76(1), 1998, pp. 115-119
Authors:
SIMOVA J
BUBENIK J
ROSSNER P
BUBENIKOVA D
JANDLOVA T
Citation: J. Simova et al., TUMOR INHIBITORY EFFECTS OF PLASMID DNA, Oncology Reports, 4(6), 1997, pp. 1161-1163
Authors:
BUBENIK J
ROSSNER P
BUBENIKOVA D
SIMOVA J
INDROVA M
SLONCOVA E
Citation: J. Bubenik et al., TUMOR VACCINES EXPRESSING IL-2, CD80, AND IL-2 PLUS CD80 GENE, International journal of oncology, 11(6), 1997, pp. 1213-1219
Authors:
ROSSNER P
BUBENIK J
INDROVA M
SOBOTA V
VONDRYS P
ZEUTHEN J
JANDLOVA T
TAKAC M
Citation: P. Rossner et al., GENETICALLY-MODIFIED TUMOR VACCINES - INSERTION OF THE IL-2 GENE DOWN-REGULATES TUMORIGENICITY MORE EFFICIENTLY THAN INSERTION OF THE CD80 GENE, International journal of oncology, 10(1), 1997, pp. 77-82
Authors:
BUBENIK J
ROSSNER P
SIMOVA J
BUBENIKOVA D
Citation: J. Bubenik et al., GENETICALLY-MODIFIED TUMOR VACCINES - TRANSDUCTION OF IL-2 AND CD80 GENE, European journal of cancer, 33, 1997, pp. 601-601
Authors:
SOBOTA V
BUBENIK J
INDROVA M
VLK V
JAKOUBKOVA J
Citation: V. Sobota et al., USE OF CRYOPRESERVED LYMPHOCYTES FOR ASSESSMENT OF THE IMMUNOLOGICAL EFFECTS OF INTERFERON THERAPY IN RENAL-CELL CARCINOMA PATIENTS, Journal of immunological methods, 203(1), 1997, pp. 1-10
Authors:
OTOVA B
PANCZAK A
SIMOVA J
JANDLOVA T
BUBENIK J
BLAZEK K
SCHRAMLOVA J
MARINOV I
Citation: B. Otova et al., TREATMENT OF TRANSPLANTED SPONTANEOUS RAT T-CELL LEUKEMIA WITH LOCAL-ADMINISTRATION OF RECOMBINANT MURINE INTERLEUKIN-2, Folia biologica, 43(1), 1997, pp. 25-32
Authors:
VONDRYS P
SIMOVA J
TAKACOVA S
JANDLOVA T
BUBENIK J
Citation: P. Vondrys et al., RECOMBINANT INTERLEUKIN-2 ACTS AS AN ADJUVANT AND HELPS TO INCREASE THE EFFICACY OF TUMOR VACCINES, Folia biologica, 43(1), 1997, pp. 39-40
Authors:
INDROVA M
PAJTASZPIASECKA E
RADZIKOWSKI C
BUBENIK J
Citation: M. Indrova et al., CTLL ASSAY - COMPARISON OF 2 METHODS FOR IL-2 DETERMINATION, Folia biologica, 43(1), 1997, pp. 45-47
Authors:
BUBENIK J
SIMOVA J
VONDRYS P
VONKA R
KITASATO H
BOSTIK P
VONKA V
Citation: J. Bubenik et al., IL-2 AS ADJUVANT FOR VACCINATION WITH CELLS MALIGNANTLY CONVERTED BY HPV-16 OR 3-MC, International journal of oncology, 8(3), 1996, pp. 477-481
Authors:
BUBENIK J
Citation: J. Bubenik, GENE-TRANSFER FOR IMMUNOTHERAPY OF CANCER, Gene therapy, 3(11), 1996, pp. 944-945
Authors:
SOBOTKOVA E
INDROVA M
SIMOVA J
BUBENIK J
VONKA V
Citation: E. Sobotkova et al., CROSS-REACTIVITY OF MURINE AND HAMSTER IL-2 MITOGENIC SIGNAL, Immunology letters, 50(1-2), 1996, pp. 115-117
Authors:
BUBENIK J
Citation: J. Bubenik, CYTOKINE GENE-MODIFIED VACCINES IN THE THERAPY OF CANCER, Pharmacology & therapeutics, 69(1), 1996, pp. 1-14
Authors:
BUBENIK J
Citation: J. Bubenik, GENETICALLY-MODIFIED TUMOR VACCINES CARRYING INSERTED GENES FOR IMMUNOREGULATORY MOLECULES, Folia biologica, 42(6), 1996, pp. 295-304
Authors:
INDROVA M
BUBENIK J
JAKOUBKOVA J
SOBOTA V
HELMICHOVA E
SIMOVA J
Citation: M. Indrova et al., IFN-ALPHA THERAPY OF RENAL-CELL CARCINOMA - DEFECT OF LYMPHOCYTE SENSITIVITY TO MITOGENIC AND ACTIVATING CYTOKINE SIGNALS IN PATIENTS NOT-RESPONDING TO THERAPY, International journal of oncology, 7(3), 1995, pp. 523-526
Authors:
BUBENIK J
Citation: J. Bubenik, CYTOKINE GENE-MODIFIED VACCINES FOR IMMUNOTHERAPY OF CANCER (REVIEW), International journal of oncology, 6(1), 1995, pp. 45-49
Authors:
BUBENIK J
BUBENIKOVA D
SIMOVA J
LOTZOVA E
Citation: J. Bubenik et al., INTERLEUKIN-2 (IL-2) AND GENE-THERAPY OF CANCER - TREATMENT OF MYELOID-LEUKEMIA WITH IRRADIATED, GENETICALLY-MODIFIED IL-2-PRODUCING CELL VACCINE, Journal of experimental & clinical cancer research, 14(1), 1995, pp. 83-86
Authors:
BUBENIK J
SIMOVA J
BUBENIKOVA D
ZEUTHEN J
INDROVA M
Citation: J. Bubenik et al., INTERLEUKIN-2 GENE-THERAPY OF RESIDUAL EL-4 LEUKEMIA POTENTIATES THE EFFECT OF CYCLOPHOSPHAMIDE PRETREATMENT, Journal of cancer research and clinical oncology, 121(1), 1995, pp. 39-43
Authors:
BUBENIK J
ZEUTHEN J
INDROVA M
BUBENIKOVA D
SIMOVA J
Citation: J. Bubenik et al., KINETICS AND FUNCTION OF PERITONEAL-EXUDATE CELLS DURING LOCAL IL-2 GENE-THERAPY OF CANCER, International journal of oncology, 4(1), 1994, pp. 13-16
Authors:
INDROVA M
BUBENIK J
JAKOUBKOVA J
SIMOVA J
JANDLOVA T
HELMICHOVA E
BENESOVA K
HESOVA M
STAHALOVA V
Citation: M. Indrova et al., SUBCUTANEOUS INTERLEUKIN-2 IN COMBINATION WITH VINBLASTINE FOR METASTATIC RENAL-CANCER - CYTOLYTIC ACTIVITY OF PERIPHERAL-BLOOD LYMPHOCYTES, Neoplasma, 41(4), 1994, pp. 197-200
Authors:
BUBENIK J
Citation: J. Bubenik, DEDICATION TO PROFESSOR SVOBODA,JAN, PHD, DSC, Folia biologica, 40(5), 1994, pp. 209-209
Authors:
BUBENIK J
SVOBODA J
Citation: J. Bubenik et J. Svoboda, LOTZOVA,EVA (1936-1994) - OBITUARY, Folia biologica, 40(3), 1994, pp. 101-102
Authors:
BUBENIK J
SIMOVA J
ZEUTHEN J
DAMANT M
JANDLOVA T
BUBENIKOVA D
Citation: J. Bubenik et al., GENE-THERAPY OF PLASMACYTOMA - COMPARISON OF THE THERAPEUTIC EFFICACYOF TUMOR-CELLS TRANSDUCED WITH THE INTERLEUKIN-2, INTERLEUKIN-4, OR INTERLEUKIN-6 GENES, Folia biologica, 40(1-2), 1994, pp. 29-36